Literature DB >> 12900280

Epitope-based vaccines: an update on epitope identification, vaccine design and delivery.

Alessandro Sette1, John Fikes.   

Abstract

The basic premise of the epitope-based approach to vaccine development is that, in certain cases, the responses induced by the natural immunogen are not optimal, and can be improved upon by isolation or optimization of specific components of the response. For example, immunodominance is a key factor limiting the type and breadth of adaptive immunity. Recent advances in understanding the mechanisms of immunodominance thus represent an opportunity to further develop the epitope-based approach.

Mesh:

Substances:

Year:  2003        PMID: 12900280     DOI: 10.1016/s0952-7915(03)00083-9

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  104 in total

1.  High-throughput engineering and analysis of peptide binding to class II MHC.

Authors:  Wei Jiang; Eric T Boder
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-09       Impact factor: 11.205

2.  A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses.

Authors:  David C Jackson; Yuk Fai Lau; Thuy Le; Andreas Suhrbier; Georgia Deliyannis; Christina Cheers; Corey Smith; Weiguang Zeng; Lorena E Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-15       Impact factor: 11.205

3.  Sculpting the immunological response to dengue fever by polytopic vaccination.

Authors:  Hao Zhou; Michael W Deem
Journal:  Vaccine       Date:  2005-12-28       Impact factor: 3.641

4.  Characterization of a permissive epitope insertion site in adenovirus hexon.

Authors:  Michael J McConnell; Xavier Danthinne; Michael J Imperiale
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

5.  A systematic bioinformatics approach for selection of epitope-based vaccine targets.

Authors:  Asif M Khan; Olivo Miotto; A T Heiny; Jerome Salmon; K N Srinivasan; Eduardo J M Nascimento; Ernesto T A Marques; Vladimir Brusic; Tin Wee Tan; J Thomas August
Journal:  Cell Immunol       Date:  2007-04-16       Impact factor: 4.868

Review 6.  Understanding the focused CD4 T cell response to antigen and pathogenic organisms.

Authors:  Jason M Weaver; Andrea J Sant
Journal:  Immunol Res       Date:  2009-02-07       Impact factor: 2.829

Review 7.  Capsid-incorporation of antigens into adenovirus capsid proteins for a vaccine approach.

Authors:  Qiana L Matthews
Journal:  Mol Pharm       Date:  2010-12-01       Impact factor: 4.939

Review 8.  Applications for T-cell epitope queries and tools in the Immune Epitope Database and Analysis Resource.

Authors:  Yohan Kim; Alessandro Sette; Bjoern Peters
Journal:  J Immunol Methods       Date:  2010-10-31       Impact factor: 2.303

9.  Construction of HCV-polytope vaccine candidates harbouring immune-enhancer sequences and primary evaluation of their immunogenicity in BALB/c mice.

Authors:  Arash Arashkia; Farzin Roohvand; Arash Memarnejadian; Mohammad Reza Aghasadeghi; Sima Rafati
Journal:  Virus Genes       Date:  2009-10-31       Impact factor: 2.332

10.  The Effects of Statistical Multiplicity of Infection on Virus Quantification and Infectivity Assays.

Authors:  Bhaven A Mistry; Maria R D'Orsogna; Tom Chou
Journal:  Biophys J       Date:  2018-06-19       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.